Seed Therapeutics
Cambridge, United States· Est. 2018
SEED Therapeutics designs molecular glue degraders using the full E3 ligase universe to eliminate disease proteins across oncology and beyond.
Private Company
Funding information not available
About
SEED Therapeutics designs molecular glue degraders using the full E3 ligase universe to eliminate disease proteins across oncology and beyond.
BiologicsSmall Molecules